These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 12296867)

  • 1. Elevated levels of soluble CD163 in sera and fluids from rheumatoid arthritis patients and inhibition of the shedding of CD163 by TIMP-3.
    Matsushita N; Kashiwagi M; Wait R; Nagayoshi R; Nakamura M; Matsuda T; Hogger P; Guyre PM; Nagase H; Matsuyama T
    Clin Exp Immunol; 2002 Oct; 130(1):156-61. PubMed ID: 12296867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of CD163+ macrophages and local production of soluble CD163 with decreased lymphocyte activation in spondylarthropathy synovitis.
    Baeten D; Møller HJ; Delanghe J; Veys EM; Moestrup SK; De Keyser F
    Arthritis Rheum; 2004 May; 50(5):1611-23. PubMed ID: 15146432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of CD147 on monocytes/macrophages in rheumatoid arthritis: its potential role in monocyte accumulation and matrix metalloproteinase production.
    Zhu P; Ding J; Zhou J; Dong WJ; Fan CM; Chen ZN
    Arthritis Res Ther; 2005; 7(5):R1023-33. PubMed ID: 16207318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for M2 macrophage activation in patients with enthesitis-related arthritis category of juvenile idiopathic arthritis.
    Bhattacharya S; Yadav A; Aggarwal A
    Clin Rheumatol; 2019 Jun; 38(6):1715-1719. PubMed ID: 30734215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monocyte CD163 is altered in association with diabetic complications: possible protective role.
    Min D; Brooks B; Wong J; Aamidor S; Seehoo R; Sutanto S; Harrisberg B; Yue DK; Twigg SM; McLennan SV
    J Leukoc Biol; 2016 Dec; 100(6):1375-1383. PubMed ID: 27354410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteolytic shedding of the macrophage scavenger receptor CD163 in multiple sclerosis.
    Fabriek BO; Møller HJ; Vloet RP; van Winsen LM; Hanemaaijer R; Teunissen CE; Uitdehaag BM; van den Berg TK; Dijkstra CD
    J Neuroimmunol; 2007 Jul; 187(1-2):179-86. PubMed ID: 17537523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophage activity assessed by soluble CD163 in early rheumatoid arthritis: association with disease activity but different response patterns to synthetic and biologic DMARDs.
    Greisen SR; Møller HJ; Stengaard-Pedersen K; Hetland ML; Hørslev-Petersen K; Junker P; Østergaard M; Hvid M; Deleuran B
    Clin Exp Rheumatol; 2015; 33(4):498-502. PubMed ID: 25962601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble macrophage-derived CD163 is a marker of disease activity and progression in early rheumatoid arthritis.
    Greisen SR; Moller HJ; Stengaard-Pedersen K; Hetland ML; Hørslev-Petersen K; Jørgensen A; Hvid M; Deleuran B
    Clin Exp Rheumatol; 2011; 29(4):689-92. PubMed ID: 21813065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of an ELISA to measure soluble CD163 in biological fluids.
    Sulahian TH; Hintz KA; Wardwell K; Guyre PM
    J Immunol Methods; 2001 Jun; 252(1-2):25-31. PubMed ID: 11334962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophage subpopulations in rheumatoid synovium: reduced CD163 expression in CD4+ T lymphocyte-rich microenvironments.
    Fonseca JE; Edwards JC; Blades S; Goulding NJ
    Arthritis Rheum; 2002 May; 46(5):1210-6. PubMed ID: 12115225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monocyte/macrophage-derived soluble CD163: a novel biomarker in multiple myeloma.
    Andersen MN; Abildgaard N; Maniecki MB; Møller HJ; Andersen NF
    Eur J Haematol; 2014 Jul; 93(1):41-7. PubMed ID: 24612259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative assessment of the recognition of domain-specific CD163 monoclonal antibodies in human monocytes explains wide discrepancy in reported levels of cellular surface CD163 expression.
    Maniecki MB; Etzerodt A; Moestrup SK; Møller HJ; Graversen JH
    Immunobiology; 2011 Aug; 216(8):882-90. PubMed ID: 21458881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infiltration of the synovial membrane with macrophage subsets and polymorphonuclear cells reflects global disease activity in spondyloarthropathy.
    Baeten D; Kruithof E; De Rycke L; Boots AM; Mielants H; Veys EM; De Keyser F
    Arthritis Res Ther; 2005; 7(2):R359-69. PubMed ID: 15743484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble CD163, a specific macrophage activation marker, is decreased by anti-TNF-α antibody treatment in active inflammatory bowel disease.
    Dige A; Støy S; Thomsen KL; Hvas CL; Agnholt J; Dahlerup JF; Møller HJ; Grønbaek H
    Scand J Immunol; 2014 Dec; 80(6):417-23. PubMed ID: 25346048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD163 expression is increased in the involved skin and sera of patients with systemic lupus erythematosus.
    Nakayama W; Jinnin M; Makino K; Kajihara I; Makino T; Fukushima S; Sakai K; Inoue Y; Ihn H
    Eur J Dermatol; 2012; 22(4):512-7. PubMed ID: 22576016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis.
    Yoshihara Y; Nakamura H; Obata K; Yamada H; Hayakawa T; Fujikawa K; Okada Y
    Ann Rheum Dis; 2000 Jun; 59(6):455-61. PubMed ID: 10834863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monocyte-lymphocyte cross-communication via soluble CD163 directly links innate immune system activation and adaptive immune system suppression following ischemic stroke.
    O'Connell GC; Tennant CS; Lucke-Wold N; Kabbani Y; Tarabishy AR; Chantler PD; Barr TL
    Sci Rep; 2017 Oct; 7(1):12940. PubMed ID: 29021532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human monocyte CD163 expression inversely correlates with soluble CD163 plasma levels.
    Davis BH; Zarev PV
    Cytometry B Clin Cytom; 2005 Jan; 63(1):16-22. PubMed ID: 15624200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of an enzyme-linked immunosorbent assay for soluble CD163.
    Møller HJ; Hald K; Moestrup SK
    Scand J Clin Lab Invest; 2002; 62(4):293-9. PubMed ID: 12476928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum levels of soluble CD163 as a specific marker of macrophage/monocyte activity in sarcoidosis patients.
    Tanimura H; Mizuno K; Okamoto H
    Sarcoidosis Vasc Diffuse Lung Dis; 2015 Jul; 32(2):99-105. PubMed ID: 26278688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.